• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管发育异常诊断中的观察者差异。

Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

作者信息

Reid B J, Haggitt R C, Rubin C E, Roth G, Surawicz C M, Van Belle G, Lewin K, Weinstein W M, Antonioli D A, Goldman H

机构信息

University of Washington, Seattle 98195.

出版信息

Hum Pathol. 1988 Feb;19(2):166-78. doi: 10.1016/s0046-8177(88)80344-7.

DOI:10.1016/s0046-8177(88)80344-7
PMID:3343032
Abstract

The potential value of biopsy surveillance of patients with Barrett's esophagus for dysplasia is diminished by a lack of agreement on the diagnostic criteria for dysplasia. In a preliminary consensus conference, experienced gastrointestinal pathologists from four medical centers agreed on criteria for a five-tiered histologic classification of dysplasia in Barrett's esophagus--negative for dysplasia, indefinite for dysplasia, low-grade dysplasia, high-grade dysplasia, and intramucosal carcinoma. Eight morphologists in the four centers tested the criteria for interobserver agreement by examining a set of coded slides that had been chosen to include some especially difficult interpretative problems in all five histologic classifications. Interobserver agreement of 85 and 87% was achieved in successive reviews when the combined group of high-grade dysplasia and intramucosal carcinoma was compared with the combined group of low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia. Comparison of other groups yielded less agreement. For example, negative for dysplasia could be distinguished from all other diagnoses with an interobserver agreement of 72%. We conclude that experienced gastrointestinal morphologists can diagnose high-grade dysplasia and intramucosal carcinoma with a high degree of agreement and thus can detect those patients who may need immediate rebiopsy or esophageal resection. Either further refinement of histologic criteria or alternate diagnostic methods will be needed to achieve the reproducible diagnosis of indefinite changes and low-grade dysplasia. This is important because patients with such changes theoretically merit closer endoscopic surveillance.

摘要

巴雷特食管发育异常患者活检监测的潜在价值因发育异常诊断标准缺乏一致性而降低。在一次初步共识会议上,来自四个医疗中心的经验丰富的胃肠病理学家就巴雷特食管发育异常的五级组织学分类标准达成了一致,即发育异常阴性、发育异常不明确、低级别发育异常、高级别发育异常和黏膜内癌。四个中心的八位形态学家通过检查一组编码玻片来测试观察者间一致性的标准,这些玻片被选择用于涵盖所有五种组织学分类中一些特别难以解释的问题。当将高级别发育异常和黏膜内癌的组合组与低级别发育异常、发育异常不明确和发育异常阴性的组合组进行比较时,在连续审查中观察者间一致性分别达到了85%和87%。其他组的比较一致性较低。例如,发育异常阴性与所有其他诊断的区分观察者间一致性为72%。我们得出结论,经验丰富的胃肠形态学家能够高度一致地诊断高级别发育异常和黏膜内癌,从而能够检测出那些可能需要立即再次活检或食管切除的患者。要实现对不明确变化和低级别发育异常的可重复诊断,需要进一步完善组织学标准或采用替代诊断方法。这很重要,因为理论上有这些变化的患者需要更密切的内镜监测。

相似文献

1
Observer variation in the diagnosis of dysplasia in Barrett's esophagus.巴雷特食管发育异常诊断中的观察者差异。
Hum Pathol. 1988 Feb;19(2):166-78. doi: 10.1016/s0046-8177(88)80344-7.
2
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.在巴雷特食管预处理活检中,高级别异型增生和腺癌的鉴别存在观察者间一致性差的情况。
Am J Gastroenterol. 2008 Sep;103(9):2333-40; quiz 2341. doi: 10.1111/j.1572-0241.2008.02020.x. Epub 2008 Jul 30.
3
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.内镜活检可以在Barrett食管中检测出高级别异型增生或早期腺癌,而无需肉眼可识别的肿瘤性病变。
Gastroenterology. 1988 Jan;94(1):81-90. doi: 10.1016/0016-5085(88)90613-0.
4
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.巴雷特食管低度发育异常的诊断及其对疾病进展的影响。
Am J Gastroenterol. 2000 Dec;95(12):3383-7. doi: 10.1111/j.1572-0241.2000.03348.x.
5
Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.美国和欧洲病理学家在诊断 Barrett 食管低级别异型增生患者中的分歧。
Gastroenterology. 2017 Feb;152(3):564-570.e4. doi: 10.1053/j.gastro.2016.10.041. Epub 2016 Nov 3.
6
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.巴雷特食管。流式细胞术与组织学在检测腺癌高危患者中的相关性。
Gastroenterology. 1987 Jul;93(1):1-11.
7
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.内镜活检方案可以区分巴雷特食管中的高级别异型增生和早期腺癌。
Gastroenterology. 1993 Jul;105(1):40-50. doi: 10.1016/0016-5085(93)90008-z.
8
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.柱状上皮发育异常与巴雷特食管中发生的浸润性腺癌之间的关系。
Am J Clin Pathol. 1987 Mar;87(3):301-12. doi: 10.1093/ajcp/87.3.301.
9
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.坚持预设的基准质量标准,有资格成为 Barrett 食管活检中不典型增生的专家评估者 - 迈向 Barrett 食管的数字审查。
United European Gastroenterol J. 2019 Aug;7(7):889-896. doi: 10.1177/2050640619853441. Epub 2019 May 21.
10
Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.巴雷特食管低级别异型增生的诊断和管理:美国胃肠病学会临床实践更新委员会的专家综述。
Gastroenterology. 2016 Nov;151(5):822-835. doi: 10.1053/j.gastro.2016.09.040. Epub 2016 Oct 1.

引用本文的文献

1
Toward next-generation endoscopes integrating biomimetic video systems, nonlinear optical microscopy, and deep learning.迈向集成仿生视频系统、非线性光学显微镜和深度学习的下一代内窥镜。
Biophys Rev (Melville). 2023 Jun 29;4(2):021307. doi: 10.1063/5.0133027. eCollection 2023 Jun.
2
PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma.PARP1 靶向荧光分子内镜作为早期检测食管异型增生和腺癌的新型工具。
J Exp Clin Cancer Res. 2024 Feb 21;43(1):53. doi: 10.1186/s13046-024-02963-7.
3
Gastro-Esophageal Junction Precancerosis: Histological Diagnostic Approach and Pathogenetic Insights.
胃食管交界部癌前病变:组织学诊断方法及发病机制见解
Cancers (Basel). 2023 Dec 6;15(24):5725. doi: 10.3390/cancers15245725.
4
FSCN1 and epithelial mesenchymal transformation transcription factor expression in human pancreatic intraepithelial neoplasia and ductal adenocarcinoma.FSCN1 和上皮间质转化转录因子在人胰腺上皮内瘤变和导管腺癌中的表达。
Pathol Res Pract. 2023 Nov;251:154836. doi: 10.1016/j.prp.2023.154836. Epub 2023 Oct 2.
5
Clinical Proteomics for Solid Organ Tissues.临床蛋白质组学用于实体器官组织。
Mol Cell Proteomics. 2023 Nov;22(11):100648. doi: 10.1016/j.mcpro.2023.100648. Epub 2023 Sep 19.
6
Real-world implementation of non-endoscopic triage testing for Barrett's oesophagus during COVID-19.COVID-19 期间 Barrett 食管非内镜分诊检测的真实世界实施。
QJM. 2023 Sep 12;116(8):659-666. doi: 10.1093/qjmed/hcad093.
7
The utility of a genetic progression risk test for Barrett esophagus.巴雷特食管遗传进展风险检测的效用。
Medicine (Baltimore). 2022 Sep 16;101(37):e30503. doi: 10.1097/MD.0000000000030503.
8
Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study.p53、Ki67 和 TLR5 在巴雷特食管癌变过程中的预测价值:一项配对病例对照研究。
Virchows Arch. 2022 Sep;481(3):467-476. doi: 10.1007/s00428-022-03340-5. Epub 2022 May 26.
9
Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia.辅助研究在 Barrett 食管和异型增生的诊断和风险评估中的作用。
Mod Pathol. 2022 Aug;35(8):1000-1012. doi: 10.1038/s41379-022-01056-0. Epub 2022 Mar 8.
10
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.巴雷特食管:肿瘤进展的病理形态和分子遗传学关键。
Cancer Med. 2022 Jan;11(2):447-478. doi: 10.1002/cam4.4447. Epub 2021 Dec 6.